Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
12/1999
12/22/1999EP0964683A1 Leukotriene antagonists for oral squamous cell carcinoma
12/22/1999CN1239474A Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
12/21/1999US6004988 Carboxylic acid derivatives, their preparation and their use
12/21/1999US6004975 Anxiolytic agents with side effect reduction
12/21/1999US6004974 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines
12/21/1999US6004971 Pentacyclic compounds, intermediates, processes, compositions, and methods
12/21/1999CA2035653C Neuroprotective 3-piperidino-4-hydrosychroman derivatives
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064043A1 Muscarinic receptor antagonists
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2315883A1 Muscarinic receptor antagonists
12/15/1999EP0963987A2 Spiro(piperidine-4,1'-pyrrolo(3,4-c)pyrrole)
12/15/1999EP0963985A2 Di-or triaza-spiro(4,5)decane derivatives
12/15/1999EP0963984A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
12/15/1999CN1238772A Novel phenanethridinium derivatives
12/14/1999US6001834 [(4-heteroaryl-1-piperazinyl)alkoxy]-3,4-dihydro-1(2h)-naphthalenones and related compounds and their therapeutic utility
12/14/1999US6001284 Organoelectroluminescence device material and organoelectroluminescence device for which the material is adapted
12/14/1999CA2186485C An improved method of synthesis for 6,9-bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione and its dimaleate salt
12/14/1999CA2027542C Uv-absorbing cyclic enaminoketones
12/08/1999EP0961617A1 Leukotriene antagonists for cerebral focal stroke
12/08/1999EP0923557A4 Stereoselective deoxygenation reaction
12/07/1999US5998620 Reacting a 6-bromopyridine compound with an amine; then carbon monoxide; alcohol in presence of palladium catalyst;then an iodo-substituted compound in presence of a base; cyclization; antihistamines
12/07/1999US5998427 Reductase inhibitor
12/07/1999US5998417 N-[(4-heteroaryl-1-piperazinyl) alkyl]phthalimides and related compounds and their therapeutic utility
12/02/1999WO1999061444A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/02/1999WO1999061424A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
12/01/1999EP0800504B1 Tricyclic retinoids, methods for their production and use
12/01/1999EP0655056B1 Azacyclyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
12/01/1999CN1046942C Imidazopyridines
11/1999
11/30/1999US5994544 Producing a 5h-chromeno(3,4-f)quinoline
11/25/1999WO1999059976A1 Improved method for preparing pharmaceutically valuable norbenzomorphane derivatives
11/25/1999WO1999059975A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999WO1999059973A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999DE19921580A1 Preparation of pure stereoisomers of new or known substituted pyrrolidine or piperidine derivatives, used e.g. as components of chiral catalysts, alkaloids or drugs
11/25/1999DE19822822A1 Norbenzomorphan derivative preparation from piperidine derivative in high yield without N-protection stage, used e.g. as pharmaceutical intermediate
11/25/1999CA2332279A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999CA2332239A1 Fused tricyclic compounds which inhibit parp activity
11/24/1999EP0959076A1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics
11/24/1999EP0959075A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
11/24/1999EP0958285A1 TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES
11/23/1999US5990122 Substituted in the 7-position by a tricyclic amine radical; reduced genotoxic properties and increased antibacterial activity
11/23/1999US5990104 Inhibiting nmda receptor activation by administering derivatives of given formula, such as 5,6,7,8,9,11,12-heptahydro-3-hydroxy-5-methyl-10-thia-5,11 -methanobenzocyclodecen-13-amine (sulphazocine)
11/23/1999US5989876 Grinding; reacting with 1,5-naphthoquinone; hair dyes
11/18/1999WO1999058500A1 Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
11/18/1999WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/17/1999EP0957102A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
11/17/1999EP0572537B1 Cytokine inhibitors
11/17/1999CN1046514C Melatonin agonist 'beta-carboline derivatives and analogs with naphthalenic structure, preparation thereof and their use as drugs
11/16/1999US5986105 Quinolone- and naphthyridonecarboxylic acid derivatives
11/16/1999US5986099 Substituted quaterrylene tetracarboxylic acid diimides
11/16/1999US5986097 Spiro[cyclopent[b]indole-piperidines]
11/16/1999US5985889 Dosage forms and method for ameliorating male erectile dysfunction
11/16/1999CA2137811C Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/11/1999WO1999043983A9 Light polarizing materials, liquid suspensions and films thereof, and light valves incorporating same
11/11/1999WO1998004528A3 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
11/10/1999CN1046283C Process for preparation of 9-amino camptothecin
11/09/1999US5981773 Reacting a corresponding perylene-3,4:9,10-tetracarboxylic dianhydride with a sterically hindered amine, as a base, at an elevated temperature
11/09/1999US5981753 Reacting a naphthalic anhydride with a polyamine and a second naphthalic anhydride
11/09/1999US5981541 Substituted heterocycles as anti-tumor agents
11/04/1999WO1999055680A1 Aryl fused azapolycyclic compounds
11/04/1999CA2330576A1 Substituted benzazocines as nicotine-binding inhibitors
11/02/1999US5977344 Dna analysis kit with intercalating fluorescent multimers; for detection of dna in electrophoresis and probes with high fluorescent efficiencies and large stokes shifts; can use single narrow wavelength band for excitation
11/02/1999US5977140 N-[(4-Heteroaryl-1-Piperidinyl)Alkly] Phthalimides and related compounds and their therapeutic utility
11/02/1999US5977128 Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
11/02/1999US5977113 4-heteroaryl-1-piperazine alkylamines and their therapeutic utility
10/1999
10/28/1999WO1999040123A3 Method for producing aqueous polymer dispersions containing colorants
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 110